Skip to main content

Animations

MJFF Publications

6201 - 6210 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2018
  • 2020
  • 2024
  • 2020
  • 2021
  • 2017
  • 2020
  • 2021
  • 2020
  • Summary Details
    RESTRICTED
    Title: Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108059
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.004
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2020.101904
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease
    Journal Name: Journal of Integrative Neuroscience
    Publisher: IMR Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.31083/j.jin2309178
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlaa160
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.08.009
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Striatal shape alteration as a staging biomarker for Parkinson’s Disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2020.102272
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-85293-4
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.